Skip to main content
logo
Kazia Therapeutics Limited (KZIA)
NASDAQ: KZIA · Real-Time Price · USD
14.03
+0.14 (1.04%)
Aug 12, 2026, 11:44 AM EDT - Market open

Kazia Therapeutics Financials Overview

Millions AUD. Fiscal year is Jul - Jun.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Revenue
-0.042.31--15.18
Revenue Growth
--98.19%----
Gross Profit
-0.042.31--15.18
Operating Income
-28.87-14.15-28.81-24.15-25.43-6.38
Net Income
-29.07-20.7-26.78-20.47-25.01-8.42
Earnings Per Share
-32.23-18.90-50.80-56.15-94.40-35.80
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Cash & Short-Term Investments
34.9639.941.665.247.3627.59
Total Debt
1.762.060.421.21.270
Net Cash (Debt)
21.5624.20.682.33.8120.68
Net Cash Growth
-10.92%3444.15%-70.25%-39.72%-81.59%242.06%
Net Cash Per Share
112.9822.091.296.2314.3787.89

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Operating Cash Flow
-19.16-13.35-9.58-15.16-22.76-9.11
Free Cash Flow
-13.04-8.78-6.39-10.1-15.7-6.83
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Gross Margin
-100.00%100.00%--100.00%
Operating Margin
--33870.10%-1248.18%---42.02%
Pretax Margin
--53749.49%-1171.97%---58.64%
Profit Margin
--49567.60%-1160.23%---55.46%
FCF Margin
--31968.80%-415.12%---60.01%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
PS Ratio
125.24369.564.95--11.43